← Back to all trials
Not Yet Recruiting
NCT07285473
Low-Dose Naltrexone For ME/CFS: Dose-Finding
Conditions: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Sex: All
Ages: 18 Years – 65 Years
Healthy volunteers: No
Phase: PHASE2
Enrollment: 75
Sponsor: University of Alabama at Birmingham
Location: University of Alabama at Birmingham Birmingham Alabama
Summary
This exploratory clinical trial tests low-dose naltrexone (LDN) for the treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). A remote trial approach is used, with eligibility open to the state of Alabama.
Eligibility Criteria
Inclusion Criteria:
* Between ages of 18 and 65
* Living in Alabama
* Meets ME-ICC criteria
Exclusion Criteria:
* Abnormal hepatic function
* Abnormal renal function
* Abnormal complete blood count
* Evidence of active or chronic systemic infection
* A1C \> 9.0%
* Current opioid analgesic use
* Pregnant or plans to become pregnant during the study participation period
* Auto-immune disorder
* Enrolled in other experimental treatment study
Source: ClinicalTrials.gov (NCT07285473). StuddyBuddy aggregates publicly available trial information.
